Bank Of America Corp Biogen Inc. Transaction History

Bank Of America Corp

$1.06 Trillion
Q1 2024

A detailed history of Bank Of America Corp transactions in Biogen Inc. stock. As of the latest transaction made, Bank Of America Corp holds 443,622 shares of BIIB stock, worth $101 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

443,622

Previous 426,574 4.0%

Holding current value

$101 Million

Previous $110 Million 13.34%

% of portfolio

0.01%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $3.61 Million - $4.56 Million	17,048 Added 4.0%	443,622 $95.7 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $22.3 Million - $26.9 Million	100,395 Added 30.78%	426,574 $110 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $44 Million - $50.8 Million	-159,731 Reduced 32.87%	326,179 $92.9 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $2.68 Million - $3.05 Million	-10,427 Reduced 2.1%	485,910 $135 Million
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $18.3 Million - $22.2 Million	-72,464 Reduced 12.74%	496,337 $137 Million

Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $26.5 Million - $36.5 Million	-136,063 Reduced 19.3%	568,801 $152 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $3.05 Million - $3.63 Million	16,280 Added 2.36%	704,864 $144 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $43.1 Million - $54.3 Million	-222,317 Reduced 24.41%	688,584 $145 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $37.6 Million - $48.4 Million	168,052 Added 22.62%	910,901 $219 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $14.3 Million - $18.7 Million	50,598 Added 7.31%	742,849 $210 Million
Q2 2021 Sep 13, 2021	BUY	$259.0 - $414.71 $179 Million - $287 Million	692,251 New	692,251 $240 Million

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Biogen Inc. Transaction History